On Monday, Noble Life Science
Partners, an advisory-focused investment and merchant banking boutique,
announced the formation of a strategic partnership agreement with JSB-Partners,
a boutique investment banking firm serving life sciences companies around the
world.
“We are excited to join forces
with JSB, as our fundamental research approach blends perfectly with JSB’s
professional culture and passionate team,” stated Nico Pronk, President and
Chief Executive Officer of Noble. “This relationship is strategic and leverages
each other’s respective core competencies… Additionally, JSB’s global reach
will position Noble to expand outside of North America.”
For the two companies, the
partnership is mutually beneficial, particularly from a strategic growth perspective.
JSB’s primary focus is on life sciences companies, which is in line with
Noble’s fastest growing research vertical. Through exhaustive fundamental
research of underlying scientific data, advanced scientific training and
plentiful healthcare experience, Noble provides clients with a strong
foundation and perspective through its industry-leading equity research. This
dedication to excellence allows Noble to expertly position growing companies
into the public markets.
JSB will be extremely beneficial
in helping these newly public clients thrive within the life sciences industry.
With key focus placed on product partnerships and private placements, JSB gives
its clients the necessary tools to successfully procure vital resources without
the need to dilute the ownership stake held by existing shareholders. The
company also gives clients expert insight into the short and long-term benefits
of potential mergers and acquisitions.
Through the newly announced
strategic partnership, the two proven companies will be able to share resources
and work under a common regulatory umbrella, expanding upon the effectiveness
of the two investment banking providers, but the potential benefits of a
long-term partnership go beyond short-term financial gains.
“While this aspect of the
relationship is attractive, it’s the opportunity to cross-leverage our
particular skill sets that excites me the most,” stated Dr. Wolfgang Stoiber,
Co-founder and Partner of JSB. “Both organizations’ clients are the
beneficiaries.”
Noble’s current range of
services includes investment banking, merchant banking and client advisory,
giving the company unfettered access to the growing life sciences vertical.
Through its strategic partnership with JSB, the company gains immediate access
to the tools necessary to increase its market presence in coming years while
expanding into the global market. Look for Noble, as well as JSB, to continue
providing clients with industry-leading investment services in the months to
come.
For more information, visit
www.novelsp.com and www.jsb-parners.com
MissionIR is committed to connecting the investment community with companies that have great potential and a strong dedication to building shareholder value. We know our reputation is based on the integrity of our clients and go to great lengths to ensure the companies represented adhere to sound business practices.
Sign up for “The Mission Report” at www.MissionIR.com
Please see disclaimer on the MissionIR website http://www.missionir.com/disclaimer.html
